Σοφ. Βενιζέλου 114, Χαλάνδρι - Τ.: 2106719422
Women with type 2 diabetes who take metformin during pregnancy to control their blood glucose levels experience a range of benefits, including reduced weight gain, reduced insulin doses, and fewer large for gestational age babies, suggest the results of a randomized controlled trial.
With the onset of influenza season and the potential overlap of influenza and COVID-19 symptoms, there is a need to be able to quickly differentiate between the two viruses to ensure that patients are appropriately managed.
Sotagliflozin, a novel type of sodium-glucose cotransporter inhibitor, showed the diverse benefits this drug class provides along with some new twists in a pair of international pivotal trials that together enrolled nearly 12,000 patients with type 2 diabetes